These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 887150)

  • 1. Macrophages isolated from regressing Moloney sarcomas are more cytotoxic than those recovered from progressing sarcomas.
    Russell SW; McIntosh AT
    Nature; 1977 Jul; 268(5615):69-71. PubMed ID: 887150
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammatory cells in solid murine neoplasms. III. Cytotoxicity mediated in vitro by macrophages recovered from disaggregated regressing Moloney sarcomas.
    Russell SW; Gillespie GY; McIntosh AT
    J Immunol; 1977 May; 118(5):1574-9. PubMed ID: 870561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 content of regressing and progressing Moloney sarcomas.
    Wechsler SJ; Eurell TE; Russell SW
    J Leukoc Biol; 1986 Aug; 40(2):159-68. PubMed ID: 3461095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory cells in solid murine neoplasms. II. Cell types found throughout the course of Moloney sarcoma regression or progression.
    Russell SW; Gillespie GY; Hansen CB; Cochrane CG
    Int J Cancer; 1976 Sep; 18(3):331-8. PubMed ID: 1085289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and persistence of cytolytic T lymphocytes in regressing or progressing Moloney sarcomas.
    Gillespie GY; Russell SW
    Int J Cancer; 1978 Jan; 21(1):94-99. PubMed ID: 304846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-T-cell-mediated cytotoxicity in MSV tumor-bearing mice. III. Macrophage-mediated cytotoxicity against autochthonous MSV tumor-isolated target cells.
    Becker S; Haskill S
    Int J Cancer; 1980 Apr; 25(4):535-41. PubMed ID: 6966262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory cells in solid murine neoplasms. IV. Cytolytic T lymphocytes isolated from regressing or progressing Moloney sarcomas.
    Gillespie GY; Hansen CB; Hoskins RG; Russell SW
    J Immunol; 1977 Aug; 119(2):564-70. PubMed ID: 301897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nature, function and distribution of inflammatory cells in regressing and progressing Moloney sarcomas.
    Russell SW; Gillespie GY
    J Reticuloendothel Soc; 1977 Aug; 22(2):159-68. PubMed ID: 72153
    [No Abstract]   [Full Text] [Related]  

  • 9. Activated macrophages as cytotoxic effector cells.
    Hibbs JB
    Transplantation; 1975 Jan; 19(1):77-81. PubMed ID: 1118889
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunity to tumours of the murine leukaemia-sarcoma virus complex.
    Owen JJ; Seeger RC
    Br J Cancer Suppl; 1973 Aug; 1():26-34. PubMed ID: 4374230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytolytic and cytostatic anti-tumor activities of macrophages from mice injected with murine sarcoma virus.
    Puccetti P; Holden HT
    Int J Cancer; 1979 Jan; 23(1):123-32. PubMed ID: 759378
    [No Abstract]   [Full Text] [Related]  

  • 12. Further evidence for the involvement of thymus-processed lymphocytes in syngeneic tumor cell cytolysis.
    Plata F; Gomard E; Leclerc JC; Levy JP
    J Immunol; 1973 Sep; 111(3):667-71. PubMed ID: 4542607
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional heterogeneity and T cell-dependent activation of macrophages from murine sarcoma virus (MSV)-induced tumors.
    Holden HT; Varesio L; Taniyama T; Puccetti P
    Adv Exp Med Biol; 1979; 121B():509-20. PubMed ID: 232622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated immunity to viral proteins in mice bearing Moloney sarcomas.
    Koppi TA; Halliday WJ
    Immunol Lett; 1982 Mar; 4(3):135-40. PubMed ID: 7076284
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor induction by murine sarcoma virus in AKR and C58 mice. Reduction of tumor regression associated with appearance of Gross leukemia virus pseudotypes.
    Chieco-Bianchi L; Colombatti A; Collavo D; Sendo F; Aoki T; Fischinger PJ
    J Exp Med; 1974 Nov; 140(5):1162-79. PubMed ID: 4608945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of macrophages and antibodies on in vivo growth of Moloney sarcoma in the rat.
    Miller GA; Feldman JD
    J Immunol; 1977 Oct; 119(4):1445-51. PubMed ID: 302284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on mouse Moloney virus induced tumours: I. The detection of p30 as a cytotoxic target on murine Moloney leukaemic spleen cells, and on an in vitro Moloney sarcoma line by antibody mediated cytotoxicity.
    Epstein LB; Knight RA
    Br J Cancer; 1975 May; 31(5):499-512. PubMed ID: 50852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated macrophages release a factor which lyses malignant cells but not normal cells.
    Currie GA; Basham C
    J Exp Med; 1975 Dec; 142(6):1600-5. PubMed ID: 1194858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro demonstration of complement-dependent cytotoxic antibodies to Moloney sarcoma cells.
    Tamerius JD; Hellström I
    J Immunol; 1974 Jun; 112(6):1987-96. PubMed ID: 4825783
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo growth and antigenic properties of a rat sarcoma induced by Moloney sarcoma virus.
    Jones JM; Jensen F; Veit B; Feldman JD
    J Natl Cancer Inst; 1974 Jun; 52(6):1771-7. PubMed ID: 4134500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.